Amolyt Pharma

Series C

Lyon, FranceJan 2023

Amolyt Pharma raised €129M in a Series C round in Jan 2023. The company is based in Lyon, France. Investors in the round: Andera Partners, ATEM, Crédit Agricole Création and 13 others. Data as of Nov 2026.

← Amolyt Pharma

Amount raised

€129M

€129,020,194

Native amount

138,000,000 USD

Stage

Series C

series c

Investors

Provenance & confidence

High confidence

Amount

138,000,000 USD

ECB-at-date → €129M · rate 1.0696 on 2023-01-09

High confidence

Source

tech.eu · own

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

16 named

Andera Partners ATEM Crédit Agricole Création CTI Life Sciences EQT Life Sciences Innobio 2 Intermediate Capital Group Kurma Partners Mass General Brigham Ventures Novo Holdings OrbiMed Pontifax Funds Relyens Innovation Santé/Turenne Capital Sectoral Asset Management Sofinnova Partners Tekla Capital Management

Date

Jan 2023

Round type

series c

Amount (EUR)

€129M

Other rounds

same company

This is the company's only recorded round.

Amolyt Pharma

Provenance & confidence

Investors in this round

Other rounds

Related news